首页 | 本学科首页   官方微博 | 高级检索  
     

血管性血友病因子在心血管疾病中的研究进展
引用本文:陈华. 血管性血友病因子在心血管疾病中的研究进展[J]. 心血管病学进展, 2010, 31(2): 229-232. DOI: 10.3969/j.issn.1004-3934.2010.02.025
作者姓名:陈华
作者单位:复旦大学附属华山医院心内科,上海,200040
摘    要:血管性血友病因子是一类主要由内皮细胞分泌的多聚糖蛋白,通过激活血小板,参与血栓形成。它与一系列心血管疾病如动脉粥样硬化、急性冠状动脉综合征、心房颤动等均关系密切,特异性抑制血管性血友病因子的新型抗血小板药物研发有望突破。

关 键 词:血管性血友病因子  血栓  冠状动脉性心脏病  抗血小板药物

von Willebrand Factor in Cardiovascular Disease
CHEN Hua. von Willebrand Factor in Cardiovascular Disease[J]. Advances in Cardiovascular Diseases, 2010, 31(2): 229-232. DOI: 10.3969/j.issn.1004-3934.2010.02.025
Authors:CHEN Hua
Affiliation:CHEN Hua1,LUO Xin-ping1,DING Jian-ping2 (1.Department of Cardiology,Huashan Hospital Affiliated to Fudan University,Shanghai 200040,China,2.Institute of Biochemistry , Cell Biology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai 200031,China)
Abstract:von Willebrand factor (vWF),a multimeric glycoprotein produced by endothelial cells.vWF is involved in thrombosis through the activation of platelets.It is closely associated with several cardiovascular diseases such as atherosclerosis,acute coronary syndromes,atrial fibrillation,and others.Moreover,several new anti-platelet drugs that specifically inhibit vWF are now being developed.In this review we discuss the relevance of vWF in cardiovascular disease and related anti-platelet drugs.
Keywords:von Willebrand factor  thrombus  coronary heart disease  anti-platelet drug
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号